We have developed several technologies specialized for designing small molecules. The input for these technologies depends on the information available: known active ligands or receptor conformation structures.
Prediction of ADME/Tox (absorption, distribution, metabolism, excretion and toxicology) properties of your small molecules of interest.
Data mining and process optimization
We apply comparative modeling to build three-dimensional protein structures in the desired conformation. Many protein structures haven’t been resolved, and even when they have, they may not be available in the desired conformation (related to protein activity or type of bound ligand).
Gaming and promotion
LandMeIn is new concept video game that extends the capabilities of a computer to solve pharmaceutical problems by exploiting human abilities to solve problems heuristically.
Luigi Di Biasi
Do you want to read our publications?
SoftMining is present in Hamburg at the BIO-Europe Conference, 25th Annual International Partnering Conference
SoftMining is present at BIONAM2019 the international conference on Bio and Nanomaterials.
SoftMining is in Genoa for the CECAM workshop on Progress and developments of artificial intelligence for drug design.
SoftMining CEO Stefano Piotto was present at CLINGLIO Meeting held in Palma in May 2019. The CLINGLIO project aims to advance a novel drug, 2OHOA, for the treatment of glioblastoma towards an initial market entry in Europe. For this purpose, the CLINGLIO project will encompass a demonstrative phase IIB clinical study to evaluate the efficacy Read more about CLINGLIO Meeting in Palma[…]
SoftMining will be present at the BIO-Europe Conference, Copenhagen 2018 – 24th Annual Partnering Conference